FDA Drug Application (020393) for ATROVENT by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number020393
Product Number001
FormSPRAY, METERED;NASAL
Dosage0.021MG/SPRAY
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameATROVENT
Active IngredientIPRATROPIUM BROMIDE

Active IngredientCount
List of drugs with Active Ingredient IPRATROPIUM BROMIDE8


Back to FDA Applications sponsored by BOEHRINGER INGELHEIM